Cargando…

PReS-FINAL-2187: Use of screening tests in patients presenting to paediatric rheumatology with suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome

Detalles Bibliográficos
Autores principales: Cruikshank, M, Anoop, P, Nikolajeva, O, Rao, A, Rao, K, Gilmour, K, Eleftheriou, D, Brogan, PA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044967/
http://dx.doi.org/10.1186/1546-0096-11-S2-O22
_version_ 1782319227444658176
author Cruikshank, M
Anoop, P
Nikolajeva, O
Rao, A
Rao, K
Gilmour, K
Eleftheriou, D
Brogan, PA
author_facet Cruikshank, M
Anoop, P
Nikolajeva, O
Rao, A
Rao, K
Gilmour, K
Eleftheriou, D
Brogan, PA
author_sort Cruikshank, M
collection PubMed
description
format Online
Article
Text
id pubmed-4044967
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40449672014-06-19 PReS-FINAL-2187: Use of screening tests in patients presenting to paediatric rheumatology with suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome Cruikshank, M Anoop, P Nikolajeva, O Rao, A Rao, K Gilmour, K Eleftheriou, D Brogan, PA Pediatr Rheumatol Online J Oral Presentation BioMed Central 2013-12-05 /pmc/articles/PMC4044967/ http://dx.doi.org/10.1186/1546-0096-11-S2-O22 Text en Copyright © 2013 Cruikshank et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Oral Presentation
Cruikshank, M
Anoop, P
Nikolajeva, O
Rao, A
Rao, K
Gilmour, K
Eleftheriou, D
Brogan, PA
PReS-FINAL-2187: Use of screening tests in patients presenting to paediatric rheumatology with suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome
title PReS-FINAL-2187: Use of screening tests in patients presenting to paediatric rheumatology with suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome
title_full PReS-FINAL-2187: Use of screening tests in patients presenting to paediatric rheumatology with suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome
title_fullStr PReS-FINAL-2187: Use of screening tests in patients presenting to paediatric rheumatology with suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome
title_full_unstemmed PReS-FINAL-2187: Use of screening tests in patients presenting to paediatric rheumatology with suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome
title_short PReS-FINAL-2187: Use of screening tests in patients presenting to paediatric rheumatology with suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome
title_sort pres-final-2187: use of screening tests in patients presenting to paediatric rheumatology with suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044967/
http://dx.doi.org/10.1186/1546-0096-11-S2-O22
work_keys_str_mv AT cruikshankm presfinal2187useofscreeningtestsinpatientspresentingtopaediatricrheumatologywithsuspectedhaemophagocyticlymphohistiocytosismacrophageactivationsyndrome
AT anoopp presfinal2187useofscreeningtestsinpatientspresentingtopaediatricrheumatologywithsuspectedhaemophagocyticlymphohistiocytosismacrophageactivationsyndrome
AT nikolajevao presfinal2187useofscreeningtestsinpatientspresentingtopaediatricrheumatologywithsuspectedhaemophagocyticlymphohistiocytosismacrophageactivationsyndrome
AT raoa presfinal2187useofscreeningtestsinpatientspresentingtopaediatricrheumatologywithsuspectedhaemophagocyticlymphohistiocytosismacrophageactivationsyndrome
AT raok presfinal2187useofscreeningtestsinpatientspresentingtopaediatricrheumatologywithsuspectedhaemophagocyticlymphohistiocytosismacrophageactivationsyndrome
AT gilmourk presfinal2187useofscreeningtestsinpatientspresentingtopaediatricrheumatologywithsuspectedhaemophagocyticlymphohistiocytosismacrophageactivationsyndrome
AT eleftherioud presfinal2187useofscreeningtestsinpatientspresentingtopaediatricrheumatologywithsuspectedhaemophagocyticlymphohistiocytosismacrophageactivationsyndrome
AT broganpa presfinal2187useofscreeningtestsinpatientspresentingtopaediatricrheumatologywithsuspectedhaemophagocyticlymphohistiocytosismacrophageactivationsyndrome